Search

Your search keyword '"Kaye, M."' showing total 35 results
Start Over Author "Kaye, M." Publisher ovid technologies (wolters kluwer health)
35 results on '"Kaye, M."'

1. Randomized Clinical Trial of Near Visual Performance with Digital Devices Using Spherical and Toric Contact Lenses

Author

Moriah A Chandler, Julia S. Benoit, Chuan Hu, Anna-Kaye M Logan, Erin S Tomiyama, Kelsea Skidmore, Eric R Ritchey, Bryan Procopio, Kathryn Richdale, James S. Wolffsohn, Ananya Datta, and Minal Bhadane

Subjects
Adult, Male, Visual acuity, media_common.quotation_subject, Visual Acuity, Astigmatism, Refraction, Ocular, law.invention, Contrast Sensitivity, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Surveys and Questionnaires, medicine, Humans, Contrast (vision), media_common, Cross-Over Studies, Computers, Contact Lenses, Hydrophilic, medicine.disease, Crossover study, Toric lens, Contact lens, Ophthalmology, Reading, 030221 ophthalmology & optometry, Optometry, Female, medicine.symptom, Psychology, 030217 neurology & neurosurgery
Abstract

SIGNIFICANCE Visual demands today incorporate a significant amount of time using digital devices. Results of this randomized crossover study of spherical and toric contact lenses demonstrated that participants were able to read smaller print size more comfortably and preferred toric contact lenses when using digital devices. PURPOSE The purpose of this study was to assess how toric contact lens correction affects subjective and objective outcomes of astigmatic patients using real-world digital devices. METHODS Adult participants, aged between 20 and 38 years with -0.75 to -1.50 D of astigmatism were enrolled in this double-masked randomized crossover 10-day study of Alcon Dailies Aqua Comfort Plus Sphere and Toric (Alcon, Geneva, Switzerland) contact lenses. Electronic high- and low-contrast near logMAR visual acuity and contrast sensitivity were tested. Reading performance was assessed using custom iPad applications; one used a reading sentences test, whereas the other analyzed zoom, contrast, and distance with website-based articles. Participants completed the Near Activity Visual Questionnaire and stated their preferred contact lens correction. RESULTS Thirty seven participants were screened, 35 participants were enrolled, and 34 participants completed the study. Toric lens correction improved near high- and low-contrast visual acuity by 0.5 to 1 full line (P < .0001) and allowed participants to read one line smaller text on the iPad (P = .01). Participants increased the zoom 11% (P = .004) and the contrast 4% (P = .006) more with spherical lenses while reading articles. Participants held the iPad at approximately the same distance, about 33 cm (P = .63). Eighty five percent of participants preferred the toric correction (P < .0001). Participants reported improved satisfaction with toric lens correction (P = .0002) and noticed the most benefit with tasks such as reading small print and labels/instructions. CONCLUSIONS This study used digital devices to demonstrate realistic benefits of toric contact lens designs for astigmatic patients.

Published
2020

2. Randomized Clinical Trial of Near Visual Performance with Digital Devices Using Spherical and Toric Contact Lenses

Author

Logan, Anna-Kaye M., primary, Datta, Ananya, additional, Skidmore, Kelsea, additional, Tomiyama, Erin S., additional, Hu, Chuan, additional, Chandler, Moriah A., additional, Procopio, Bryan, additional, Bhadane, Minal, additional, Benoit, Julia S., additional, Ritchey, Eric R., additional, Wolffsohn, James S., additional, and Richdale, Kathryn, additional

Published
2020
Full Text
View/download PDF

3. Frequency of Subtypes of Biliary Intraductal Papillary Mucinous Neoplasm and Their MUC1, MUC2, and DPC4 Expression Patterns Differ from Pancreatic Intraductal Papillary Mucinous Neoplasm

Author

David A. Barrett, Kaye M. Reid-Lombardo, Thomas C. Smyrk, Guido M. Sclabas, Michael L. Kendrick, Saboor Khan, David M. Nagorney, Florencia G. Que, John H. Donohue, and Joshua Barton

Subjects
Pathology, medicine.medical_specialty, endocrine system diseases, Locus (genetics), Mothers against decapentaplegic homolog 4, medicine, Humans, MUC1, Smad4 Protein, Mucin-2, Intraductal papillary mucinous neoplasm, business.industry, Mucin-1, Mucin, medicine.disease, Adenocarcinoma, Mucinous, Carcinoma, Papillary, Pancreatic Neoplasms, Biliary Tract Neoplasms, Carcinoma, Intraductal, Noninfiltrating, medicine.anatomical_structure, Surgery, Histopathology, Pancreas, business, Immunostaining
Abstract

Background Biliary intraductal papillary mucinous neoplasm (B-IPMN) has been proposed as a unique clinicopathologic disease with distinct histopathologic features, although wide acceptance remains controversial. A recent consensus conference classified pancreatic IPMN (P-IPMN) into 4 subtypes (ie, gastric, intestinal, pancreatobiliary, oncocytic) based on morphologic appearance and mucin (MUC) staining properties. The aim of this study was to determine whether B-IPMN has similar histopathologic and immunologic subtypes to P-IPMN. Study Design Specific immunostaining for MUC1, MUC2, and deleted for pancreas cancer, locus 4 were performed on specimens from 19 patients with a histopathologic diagnosis of B-IPMN. Immunostaining patterns of B-IPMN were correlated with histopathology. Results Based on histopathology, the following subtypes of B-IPMN were identified: pancreatobiliary n=9 (47%), intestinal n=8 (42%), oncocytic n=2 (11%), and gastric n=0 (0%). Pancreatobiliary and oncocytic subtypes of B-IPMN were positive for MUC1 and negative for MUC2, and intestinal subtypes were positive for MUC2 and negative for MUC1. Thirteen of the 19 B-IPMN were associated with invasive carcinoma; loss of deleted for pancreas cancer, locus 4 was found in 6 of 13 invasive components and in 3 of 19 noninvasive components of B-IPMN. Five-year survival for patients with resected B-IPMN and invasive carcinoma was 38%, which is similar to that for resected P-IPMN with invasive carcinoma. Conclusions Histopathologic subtypes and type-specific MUC expression patterns of B-IPMN resemble those of P-IPMN. MUC1 expression and/or absence of MUC2 expression, which correlate with aggressive features of P-IPMN, were found in B-IPMN and correlate with invasive B-IPMN. Loss of deleted for pancreas cancer, locus 4 parallels the findings observed in P-IPMN. These findings provide additional support that B-IPMN is a unique entity with similarities to main duct P-IPMN.

Published
2012

4. Diagnosis and Treatment of Mirizzi Syndrome: 23-Year Mayo Clinic Experience

Author

John M. Donohue, Young Erben, Luis A. Benavente-Chenhalls, Florencia G. Que, Michael L. Kendrick, Michael B. Farnell, Kaye M. Reid-Lombardo, and David M. Nagorney

Subjects
Adult, Male, medicine.medical_specialty, Abdominal pain, medicine.medical_treatment, Postoperative Complications, medicine, Humans, Laparoscopy, Aged, Retrospective Studies, Aged, 80 and over, Endoscopic retrograde cholangiopancreatography, medicine.diagnostic_test, business.industry, Bile duct, Patient Selection, Standard treatment, Middle Aged, Mirizzi Syndrome, Surgery, Hospitalization, Treatment Outcome, medicine.anatomical_structure, Cholecystectomy, Laparoscopic, Common hepatic duct, Cystic duct, Female, Cholecystectomy, Bile Ducts, medicine.symptom, business
Abstract

Background Mirizzi syndrome (MS) is characterized by extrinsic compression of the common hepatic duct by stones impacted in the cystic duct or gallbladder neck. Open cholecystectomy (OC) has been the standard treatment; however, laparoscopy has challenged this approach. Study Design The objective of this study was to review our clinical experience with MS since the introduction of laparoscopic cholecystectomy (LC) and determine the impact of alternative approaches. We conducted a retrospective review of patients with MS from January 1987 to December 2009. Results There were 36 patients with MS among 21,450 cholecystectomies (frequency 0.18%). Seventeen were women. The most common presenting symptoms were abdominal pain (n = 23) and jaundice (n = 19). Preoperative diagnostic studies included ultrasonography (n = 27), CT (n = 24), and endoscopic retrograde cholangiopancreatography (n = 32). Cholecystectomy was performed in 35 patients; LC was initiated in 15 and OC in 21. Conversion rate from LC to OC was 67%. Five patients who had successful LC had type I MS. Of the patients who underwent LC with conversion or OC, 14 had type I and 16 had type II MS. The cystic duct for type I and the bile duct for type II MS were managed diversely according to surgeon's preference. There was no operative mortality. Morbidity was 31% with Clavien class I in 2, IIIa in 4, IIIb in 1, and IV in 3 patients. Mean hospitalization was 9 days (range 2 to 40 days). Mean follow-up was 37 months (range 1 to 187 months). Conclusions Low incidence and nonspecific presentation of MS precludes referral and substantive individual experience. Although LC may be applicable in selected patients with type I MS, OC remains the standard of care.

Published
2011

5. Hepatic Resection for the Carcinoid Syndrome in Patients with Severe Carcinoid Heart Disease: Does Valve Replacement Permit Safe Hepatic Resection?

Author

Hartzell V. Schaff, David M. Nagorney, Florencia G. Que, Kaye M. Reid-Lombardo, John H. Donohue, Michael L. Kendrick, Joseph B. Lillegard, Heidi M. Connolly, Travis J. McKenzie, Michael B. Farnell, and James E. Fisher

Subjects
Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Carcinoid Heart Disease, Cohort Studies, Valve replacement, medicine, Hepatectomy, Humans, cardiovascular diseases, Survival rate, Aged, Heart Valve Prosthesis Implantation, business.industry, Liver Neoplasms, Case-control study, Cancer, Middle Aged, medicine.disease, Surgery, Survival Rate, Treatment Outcome, Case-Control Studies, Female, business, Carcinoid syndrome, Cohort study
Abstract

Background Hepatic resection of metastatic carcinoid cancer can prolong survival and control symptomatic endocrinopathy. Decompensated carcinoid heart disease (CHD) can develop in some patients with metastatic carcinoid cancers, which can preclude operation for resectable hepatic metastases. We hypothesized that outcomes after hepatic resection for patients with the carcinoid syndrome after valve replacement for CHD would be similar to carcinoid patients without CHD. Study Design We compared the survival and symptom control after hepatic resection for patients undergoing valve replacement for CHD to carcinoid patients without CHD matched for age, sex, and extent of hepatectomy. Results Fourteen patients with earlier valve replacement for CHD were compared with 28 carcinoid patients without CHD. All patients had hepatic resection for metastatic carcinoid disease and carcinoid syndrome. Mean age, sex distribution, and extent of hepatectomy (major hepatectomy, 78%) was similar between groups. Mean interval from valve replacement to hepatectomy was 101 days. There was no operative mortality. Major operative morbidity, inclusive of operative blood loss and cardiorespiratory events, occurred in 28.5% and 14.2% for CHD and non-CHD groups, respectively (p = 0.16). Symptom-free survival for CHD and non-CHD groups was 69% and 81% at 1 year (p = 0.22) and 61% and 44% (p = 0.17) at 5 years, respectively. Octreotide-free survival after hepatectomy 69% and 84% (p = 0.15) at 1 year and 62% and 52% (p = 0.29) 5 years, respectively. Overall survival CHD and non-CHD groups 100% at 1 year and 100% and 70% (p = 0.002) 5 years. Conclusions Valve replacement for severe CHD is safe and hepatic resection is associated with similar outcomes as patients without CHD undergoing hepatic resection for carcinoid syndrome. Identifying resectable hepatic metastases from carcinoids in patients with severe CHD should prompt valve replacement and interval hepatic resection.

Published
2011

6. Frequency of Extrapancreatic Neoplasms in Intraductal Papillary Mucinous Neoplasm of the Pancreas

Author

Kaye M. Reid-Lombardo, Christina M. Wood, William S. Harmsen, Michael G. Sarr, and Kellie L. Mathis

Subjects
Male, Pathology, medicine.medical_specialty, Pancreatic disease, endocrine system diseases, Neoplasms, Multiple Primary, Pancreatic cancer, Carcinoma, Humans, Medicine, In patient, Aged, Intraductal papillary mucinous neoplasm, business.industry, Cancer, medicine.disease, Adenocarcinoma, Mucinous, Carcinoma, Papillary, Pancreatic Neoplasms, stomatognathic diseases, medicine.anatomical_structure, Adenocarcinoma, Female, Surgery, business, Pancreas, Carcinoma, Pancreatic Ductal
Abstract

To estimate the frequency of extrapancreatic neoplasms in patients with IPMN compared with those with ductal pancreatic cancer and a general referral population.Several studies have reported an increased risk of extrapancreatic neoplasms in patients with IPMN, but these studies focused only on those patients who underwent resection and excluded those patients treated nonoperatively.All patients diagnosed with IPMN at Mayo Clinic from 1994 to 2006 were identified. Two control groups consisting of Group 1-patients with a diagnosis of ductal pancreatic adenocarcinoma (1:1) and Group 2-a general referral population (3:1) were matched for gender and age at diagnosis, year of registration, and residence. Logistic regression was used to assess the risk of a diagnosis of extrapancreatic neoplasms among cases versus controls.There were 471 cases, 471 patients in Group 1, and 1413 patients in Group 2. The proportion of IPMN patients having any extrapancreatic neoplasm diagnosed before or coincident to the index date was 52% (95% CI, 47%-56%), compared with 36% (95% CI, 32%-41%) in Group 1 (P0.001), and 43% (95% CI, 41%-46%) in Group 2 (P = 0.002). Benign neoplasms most frequent in the IPMN group were colonic polyps (n = 114) and Barrett's neoplasia (n = 18). The most common malignant neoplasms were nonmelanoma skin (n = 35), breast (n = 24), prostate (n = 24), colorectal cancers (n = 19), and carcinoid neoplasms (n = 6).Patients with IPMN have increased risk of harboring extrapancreatic neoplasms. Based on the frequency of colonic polyps, screening colonoscopy should be considered in all patients with IPMN.

Published
2010

7. Incidence, Prevalence, and Management of Intraductal Papillary Mucinous Neoplasm in Olmsted County, Minnesota, 1984-2005

Author

Kaye M. Reid-Lombardo, Florencia G. Que, Jennifer L. St. Sauver, K. Krishnan Unni, Zhuo Li, and William A. Ahrens

Subjects
Adult, Male, medicine.medical_specialty, Time Factors, endocrine system diseases, Minnesota, Endocrinology, Diabetes and Metabolism, Population, Article, Endocrinology, Internal Medicine, medicine, Humans, education, Survival rate, Aged, Aged, 80 and over, education.field_of_study, Hepatology, Intraductal papillary mucinous neoplasm, business.industry, Incidence (epidemiology), Papillary Neoplasm, General surgery, Middle Aged, medicine.disease, Adenocarcinoma, Mucinous, Carcinoma, Papillary, Pancreatic Neoplasms, Survival Rate, Population study, Female, business, Carcinoma, Pancreatic Ductal, Incidence prevalence
Abstract

Intraductal mucinous papillary neoplasm (IPMN) is being recognized with increasing frequency around the world. The true incidence, however, remains unknown. Our goal was to determine the incidence of IPMN in a population study.We used the records-linkage system of the Rochester Epidemiology Project to ascertain age- and sex-adjusted incidence rates of IPMN in Olmsted County, Minn, from January 1, 1984, to December 31, 2005. We also evaluated the number of prevalent cases as of December 31, 2005.We identified 28 incident cases of IPMN. The age- and sex-adjusted cumulative incidence for IPMN in Olmsted County is 2.04 cases per 100,000 persons (95% confidence interval [CI], 1.28-2.80) from 1984 to 2005. Point prevalence on December 31, 2005, was 25.96 cases per 100,000 persons (95% CI, 14.53-37.38 cases) or 1 per 3852. Restricting to county residents 60 years and older, the point prevalence is 99.10 cases per 100,000 persons (95% CI, 54.40-143.79 cases) or one per 1009 persons. Thirty-two percent of patients were treated surgically. The 5-year survival rate after diagnosis was 59.6%.The incidence of IPMN in Olmsted County is low but increasing. Most patients do not die of complications related to the disease.

Published
2008

13. Frequency of Subtypes of Biliary Intraductal Papillary Mucinous Neoplasm and Their MUC1, MUC2, and DPC4 Expression Patterns Differ from Pancreatic Intraductal Papillary Mucinous Neoplasm

Author

Sclabas, Guido M., primary, Barton, Joshua G., additional, Smyrk, Thomas C., additional, Barrett, David A., additional, Khan, Saboor, additional, Kendrick, Michael L., additional, Reid-Lombardo, Kaye M., additional, Donohue, John H., additional, Nagorney, David M., additional, and Que, Florencia G., additional

Published
2012
Full Text
View/download PDF

15. Comparison of two-stage hepatectomy and single-stage hepatectomy after downstaging by chemotherapy for the treatment of initially unresectable colorectal liver metastases: A meta-analysis

Author

Irada Ibrahim-zada and Kaye M. Reid Lombardo

Subjects
Oncology, Chemotherapy, medicine.medical_specialty, Multivariate analysis, Blood transfusion, business.industry, medicine.medical_treatment, Anastomosis, medicine.disease, Gastroenterology, Two stage hepatectomy, Diabetes mellitus, Meta-analysis, Internal medicine, medicine, Surgery, Hepatectomy, business
Abstract

RESULTS: There were 619(55%) cervical and 509(48%) thoracic anastomoses. Cervical anastomosis was associated with a longer median operative time (329min. vs. 316min., p 0.006), greater than 2 units of blood transfusion in a higher proportion of patients (10% vs. 4%, p 0.001), and higher superficial surgical site infections (13% vs. 8%, p 0.01). There were no difference in rates of organ/space infections (6% vs. 7%, p 0.45), overall morbidity (38% vs. 37%, p 0.60), or mortality (3% vs. 4%, p 0.54). Median length of stay was similar (12days cervical vs. 11days thoracic, p 0.20), even among patients with organ/space infections (19days cervical vs. 22 days thoracic, p 0.58). On multivariate analysis, significant predictors for overall morbidity included: diabetes (aOR 1.7: 95%CI 1.092.67) and pre-operative pulmonary infection (aOR 2.26: 95%CI 1.17-4.48).

Published
2012

19. 93rd annual convention podium and poster abstracts

Author

Davis, C. M., primary, Strong, S. A., additional, Hellinger, M. D., additional, Williamson, P. R., additional, Larach, S. W., additional, Ferrara, A., additional, Blake, T. B., additional, Medich, D. S., additional, Ziv, Y., additional, Oakley, J. R., additional, Reissman, P., additional, Piccirillo, M., additional, Ulrich, A., additional, Nogueras, J. J., additional, Wexner, S. D., additional, Rubin, M. S., additional, Bodenstein, L. E., additional, Kent, K. C., additional, Williamson, M. E.R., additional, Lewis, W. G., additional, Sagar, P. M., additional, Holdsworth, P. J., additional, Johnston, D., additional, Fazio, V. W., additional, Goldblum, J. R., additional, Sirimarco, M. T., additional, Lavery, I. C., additional, Petras, R. E., additional, Treem, W. R., additional, Cohen, J., additional, Davis, P. M., additional, Hyams, J. S., additional, Eu, K. W., additional, Bartolo, D. C.C., additional, Green, J. D., additional, Riether, R. D., additional, Rosen, L., additional, Stasik, J. J., additional, Sheets, J. A., additional, Reed, J., additional, Khubchandani, I. T., additional, Armitage, N. C., additional, Chapman, M., additional, Hardcastle, J. D., additional, Viamonte, M., additional, Plasencia, G., additional, Wiltz, O., additional, Jacobs, M., additional, Finan, P. J., additional, Passaro, M., additional, Church, J. M., additional, McGannon, E., additional, Wilson, M., additional, Hull-Boiner, S., additional, Kollmorgen, C. F., additional, Meagher, A. P., additional, Wolff, B. G., additional, Pemberton, J. H., additional, Martenson, J. A., additional, Ilstrup, D. M., additional, Moran, M. R., additional, Ramos, A., additional, Rothenberger, D. A., additional, Goldberg, S. M., additional, Johnson, D., additional, Madoff, R. D., additional, Wong, W. D., additional, Finne, C. O., additional, Konishi, F., additional, Furuta, K., additional, Kanazawa, K., additional, Lockhart, D., additional, Schmitt, S., additional, Caushaj, P. P., additional, Garcia-Aguilar, J., additional, Belmonte, C., additional, Schiesel, E. C., additional, Mazier, W. P., additional, Senagore, A. J., additional, Piccirillo, M. F., additional, Teoh, T.-A., additional, Yoon, K.-S., additional, Paul, R.A. Patino, additional, Lucas, J., additional, Nelson, R., additional, Norton, N., additional, Cautley, E., additional, Schouten, W. R., additional, Briel, J. W., additional, Auwerda, J. J.A., additional, de Graaf, E. J.R., additional, Lowry, A. C., additional, Sentovich, S. M., additional, Blatchford, G. J., additional, Rivela, L. J., additional, Thorson, A. G., additional, Christensen, M. A., additional, Jorge, J. M.N., additional, Yang, Y. K., additional, Shafik, A., additional, Allendorf, J. D.F., additional, Kayton, M. L., additional, Libutti, S. K., additional, Trokel, M. J., additional, Whelan, R. L., additional, Treat, M. R., additional, Nowygrod, R., additional, Bessler, M., additional, Frank, R. E., additional, Saclarides, T. J., additional, Leurgans, S., additional, Speziale, N. J., additional, Drab, E., additional, Rubin, D., additional, Hull, T. L., additional, Schroeder, T. K., additional, Scholefield, J. H., additional, Ogunbiyi, O. A., additional, Smith, J. H.F., additional, Rogers, K., additional, Sharp, F., additional, Longo, W. E., additional, Vernava, A. M., additional, Wade, T. P., additional, Coplin, M. A., additional, Virgo, K. S., additional, Johnson, F. E., additional, Brady, M., additional, Kavolius, J., additional, Quan, S. H.Q., additional, Goldstein, E. T., additional, Feldman, S., additional, Shub, H. A., additional, Bennett, D. R., additional, Kumar, R., additional, McMillen, M. A., additional, Thornton, S., additional, Khoury, D. A., additional, Opelka, F. G., additional, Teoh, T-A., additional, Cohen, S. M., additional, Weiss, E. G., additional, Ortiz, H., additional, De Miguel, M., additional, Armendáriz, P., additional, Rodriguez, J., additional, Chocarro, C., additional, Farouk, R., additional, Dorrance, H. R., additional, Duthie, G. S., additional, Rainey, J. B., additional, Morgado, P. J., additional, Corman, M. L., additional, Kawamura, Y. J., additional, Sawada, T., additional, Muto, T., additional, Nagai, H., additional, Hill, J., additional, MacLennan, I., additional, Binderow, S. R., additional, Daniel, N., additional, Ehrenpreis, E. D., additional, Jensen, J. E., additional, Bonner, G. F., additional, Ruderman, W. B., additional, Milsom, J. W., additional, Gibbs, D. H., additional, Beck, D. E., additional, Hicks, T. C., additional, Timmcke, A. E., additional, Gathright, J. B., additional, Cheong, D., additional, Lucas, F. V., additional, McGinity, M., additional, Taylor, B. A., additional, Godwin, P., additional, Holdsworth, P., additional, Lewis, W., additional, Quirke, P., additional, Williamson, M., additional, Kokoszka, J., additional, Pavel, D., additional, Abcarian, H., additional, Stephenson, B. M., additional, Morgan, A. R., additional, Salaman, J. R., additional, Wheeler, M. H., additional, Tran, T. C.K., additional, Willemsen, W., additional, Kuijpers, H. C., additional, Lehman, J. F., additional, Wiseman, J. S., additional, MacFie, J., additional, Sedman, P., additional, May, J., additional, Mancey-Jones, B., additional, Johnstone, D., additional, Nwariaku, F. E., additional, Rochon, R. B., additional, Huber, P. J., additional, Carrico, C. J., additional, Ortega, A., additional, Beart, R., additional, Winchester, D., additional, Steele, G., additional, Green, R., additional, Caushaj, P. F., additional, Devereaux, D., additional, Griffey, S., additional, Reiver, D., additional, Kmiot, W. A., additional, Baker, R., additional, Luchtefeld, M. A., additional, Anthone, G., additional, Schlinkert, R., additional, Roig, J. V., additional, Villoslada, C., additional, Solana, A., additional, Alos, R., additional, Hinojosa, J., additional, Lledo, S., additional, Johnson, D. R.E., additional, Buie, W. D., additional, Jensen, L. L., additional, Heine, J., additional, Hoffmann, B., additional, Timmcke, A., additional, Hicks, T., additional, Opelka, F., additional, Beck, D., additional, Sousa, A., additional, Araùjo, S. A., additional, Damico, F. M., additional, Cordeiro, A. C., additional, Pinotti, H. W., additional, Gama, A. H., additional, Fengler, S., additional, Pearl, R., additional, Orsay, C., additional, Seow-Choen, F., additional, Ho, J. M.S., additional, Wiltz, O. H., additional, Torregrosa, M., additional, Brasch, R. C., additional, Bufo, A. J., additional, Krienberg, P., additional, Johnson, G. P., additional, Gowen, G. F., additional, Mullen, P. D., additional, Behrens, D., additional, Hughes, T. G., additional, Wynn, M., additional, Pollack, J. S., additional, Rajagopal, A. S., additional, Huynh, T., additional, Schanbacher, C., additional, Hickson, W. G.E., additional, Yang, Y.-K., additional, Heymen, S., additional, Choi, S.-K., additional, Vaccaro, C. A., additional, Teoh, T. A., additional, Choi, S. K., additional, Cheong, D. M.O., additional, Salanga, V. D., additional, MacDonald, A., additional, Baxter, J. N., additional, Finlay, I. G., additional, Mellgren, A., additional, Bremmer, S., additional, Dolk, A., additional, Gillgren, P., additional, Johansson, C., additional, Ahlbäck, S. O., additional, Udén, R., additional, Holmström, B., additional, O'Donovan, S., additional, Neto, J.A. Reis, additional, Ciquini, S., additional, Quilici, F. A., additional, Reis, J. A., additional, Torrabadella, L., additional, Salgado, G., additional, Horvath, K. D., additional, Golub, R., additional, Ahsan, H., additional, Cirocco, W., additional, Lavery, L. C., additional, Alós, R., additional, García-Granero, E., additional, Uribe, N., additional, Sala, C., additional, Ozuner, G., additional, Daniels, G., additional, Lieberman, R. C., additional, Polites, G., additional, Deshpande, Y., additional, Niehoff, M., additional, Chandel, B., additional, Berglund, D. D., additional, Gemlo, B. T., additional, Spencer, M. P., additional, Marcello, P. W., additional, Roberts, P. L., additional, Schoetz, D. J., additional, Murray, J. J., additional, Coller, J. A., additional, Veidenheimer, M. C., additional, Koltun, W. A., additional, Bloomer, M. M., additional, Colony, P., additional, Ruggeiro, F., additional, Fleshner, P. R., additional, Michelassi, F., additional, Finan, P., additional, Ash, D., additional, Antonenko, D. R., additional, Khanduja, K. S., additional, Fitzgerald, S. D., additional, Moniz-Pereira, P., additional, Outwater, E. K., additional, Marks, G. J., additional, Mohiuddin, M., additional, Hartley, M. N., additional, Holbrook, R. F., additional, Rodriguez-Bigas, M. A., additional, Ramakrishnan, K., additional, Palmer, M. L., additional, Petrelli, N. J., additional, Takahashi, T., additional, Nivatvongs, S., additional, Batts, K. P., additional, Lucas, S. W., additional, Klein, S. N., additional, Keidan, R. D., additional, Bannon, J. P., additional, Zhou, J., additional, Hunt, L. M., additional, Robinson, M. H., additional, Hugkulstone, C. E., additional, Clarke, B., additional, Vernon, S. A., additional, Gregson, R. H., additional, Ryan, M., additional, Dutta, S., additional, Levine, A., additional, Dominguez, J. M., additional, Bolan, P., additional, Bines, S. D., additional, Adachi, M., additional, Watanabe, T., additional, Okinaga, K., additional, Hase, K., additional, Shatney, C., additional, Mochizuki, H., additional, Ure, T., additional, Dehghan, K., additional, Andrus, C. A., additional, Daniel, G. L., additional, D'Emilia, J. C., additional, Rodriguez-Bigas, M., additional, Suh, O. K., additional, Brewer, D. A., additional, Fung, C., additional, Chapuis, P., additional, Bokey, E. L., additional, Garcia, J. C., additional, Banerjee, S., additional, Remzi, F. H., additional, Ger, G. C., additional, Gonzalez, L., additional, Gee, A. S., additional, Roe, A. M., additional, Durdey, P., additional, Kaye, M. D., additional, Kyzer, S., additional, Gordon, P. H., additional, Hasegawa, M., additional, Bun, Tae P., additional, Ikeuchi, D., additional, Onodera, H., additional, Imamura, M., additional, Maetani, S., additional, Blake, T., additional, Hellinger, M., additional, Grewal, H., additional, Klimstra, D. S., additional, Cohen, A. M., additional, Guillem, J. G., additional, Rooney, P. S., additional, Gifford, K.-A., additional, Clarke, P. A., additional, Kuhn, J. A., additional, Bryce, K., additional, Frank, N., additional, Dignan, R. D., additional, Lichliter, W. E., additional, Franko, E., additional, Jacobson, R. M., additional, Preskitt, J. T., additional, Lieberman, Z., additional, Tulanon, P., additional, Steinbach, H., additional, McCarty, T., additional, Simons, T., additional, Chen, W. S., additional, Leu, S. Y., additional, Hsu, H., additional, Halverson, A., additional, Congilosi, S., additional, Madoff, R., additional, Rothenberger, D., additional, Paterson, R., additional, Cartmill, J. A., additional, Gingold, B. S., additional, Cooper, M., additional, Gorfine, S. R., additional, Bauer, J. J., additional, Gelernt, I. M., additional, Kreel, I., additional, Harris, M. T., additional, Vallejo, J. F., additional, Kestenberg, A., additional, Miyajima, N., additional, Kano, N., additional, Ishikawa, Y., additional, Sakai, S., additional, Yamakawa, T., additional, Otchy, D. P., additional, Van Heerden, J. A., additional, Weaver, A. L., additional, Winter, L. D., additional, Mav, J., additional, Lee, P. Y., additional, Vetto, J. T., additional, Sullivan, E. S., additional, Rabkin, J., additional, Mayoral, J. L., additional, Matas, A. J., additional, Bove, P., additional, Visser, T., additional, Barkel, D., additional, Villalba, M., additional, Bendick, P., additional, Glover, J., additional, Golub, R. W., additional, Cirocco, W. C., additional, Altringer, W., additional, Domingues, J. M., additional, Brubaker, L. T., additional, Smith, C. S., additional, Kumar, S., additional, and Gilbert, P., additional

Published
1994
Full Text
View/download PDF

21. Offering consultations on rehabilitation skills to nursing homes

Author

Kaye M. McIntyre and Marie Welch

Subjects
medicine.medical_specialty, Rehabilitation, Nursing, business.industry, medicine.medical_treatment, Family medicine, medicine, Physical Therapy, Sports Therapy and Rehabilitation, Geriatrics and Gerontology, business, Nursing homes
Published
1987

35. Reality Shock In Reverse

Author

Patricia Grant Higgins and Kaye M. Wolfarth

Subjects
General Medicine, General Nursing
Published
1981

Catalog

Books, media, physical & digital resources
See catalog results